Summary: Cultured cortical neurons deprived of glucose in a defined solution containing 2 mM glutamine became acutely swollen and went on to degenerate over the next day; this neuronal loss could be substantially attenuated by an N-methyl-D-aspartate (NMDA) antagonist. Re moval of extracellular glutamine produced two effects: an increase in overall neuronal injury and a decrease in the protective effect of an NMDA antagonist. Both effects of glutamine removal were glutamine concentration depen dent (ECso for both � 300 /-LM) and not reversed by subSeveral studies support the hypothesis that the neuronal damage associated with hypoglycemia, like that associated with hypoxia-ischemia, is in part mediated by the excess release of excitatory amino acid neurotransmitters and the subsequent neurotoxic overstimulation of postsynaptic gluta mate receptors (Auer, 1986; Siesjo, 1988) . There is an increase of glutamate and aspartate in the extra cellular space during hypoglycemia (Sandberg et ai., 1986), and transection of the glutamatergic cor ticostriatal pathway ameliorates damage in the ipsi lateral striatum (Wieloch et ai., 1985). Furthermore, N-methyl-D-aspartate (NMDA) antagonists have been shown to provide protection against hypogly cemic neuronal loss in vivo (Wieloch, 1985) and glu cose deprivation-induced neuronal loss in vitro .
Several studies support the hypothesis that the neuronal damage associated with hypoglycemia, like that associated with hypoxia-ischemia, is in part mediated by the excess release of excitatory amino acid neurotransmitters and the subsequent neurotoxic overstimulation of postsynaptic gluta mate receptors (Auer, 1986; Siesjo, 1988) . There is an increase of glutamate and aspartate in the extra cellular space during hypoglycemia (Sandberg et ai., 1986) , and transection of the glutamatergic cor ticostriatal pathway ameliorates damage in the ipsi lateral striatum (Wieloch et ai., 1985) . Furthermore, N-methyl-D-aspartate (NMDA) antagonists have been shown to provide protection against hypogly cemic neuronal loss in vivo (Wieloch, 1985) and glu cose deprivation-induced neuronal loss in vitro .
While many metabolic pathways can lead to the production of glutamate or aspartate, the synthesis stitution of equimolar concentrations of alanine or argin ine. These observations suggest that glucose deprivation neuronal injury may be tonically regulated by the pres ence of extracellular glutamine. We speculate that glu tamine may reduce overall injury by serving as an energy substrate in the absence of glucose, but may increase NMDA receptor-mediated injury by serving as a precur sor for transmitter excitatory amino acids. Key Words: Aspartate-Cell culture-Excitotoxicity-Glutamate Glutamine-H ypoglycemia-Ischemia-Neurotoxicity.
of neurotransmitter pools of these substances by neuronal presynaptic terminals may depend impor tantly on the availability of extracellular glutamine, normally supplied by surrounding glial cells as part of the "glutamate-glutamine cycle" (Bradford et ai., 1978; Hamberger et ai., 1979; Ward et ai., 1983) . Neuronal vulnerability to injury by glucose depri vation may therefore also depend on the availability of extracellular glutamine. Of note, a fall in extra cellular glutamine concentration in the rat striatum (Engelsen and Fonnum, 1983) and a fall in tissue glutamine content in rat hippocampal slices (Szerb and O'Regan, 1987) have been found to occur under conditions of glucose deprivation. The latter au thors also directly demonstrated that the potassium evoked release of glutamate and aspartate could be enhanced by glutamine both at normal and at re duced glucose levels.
The ideal that the availability of extracellular glu tamine might modulate glucose deprivation neuro nal injury is further supported by our previous ob servation that hypoxic neuronal injury in cortical cell cultures can be attenuated by removal of me dium glutamine (Goldberg et ai., 1988) . However, hypoxia and hypoglycemia induce substantially dif ferent alterations in brain metabolism (Auer and Siesjo, 1988) . The present study was performed to directly examine the relationship between extracel lular glutamine concentration and glucose depriva tion neuronal injury in cortical cell cultures. An ab stract has appeared (Monyer et aI., 1988) .
MATERIALS AND METHODS

Cortical cell culture
Mixed cortical cell cultures, containing both neuronal and glial elements, were prepared as previously described (Choi et aI., 1987) from fetal mice at 14-17 days of ges tation. Dissociated cortical cells were plated in Primaria (Falcon) 15-mm multiwell vessels (-2.8 x 105 cells/well) in Eagle's minimal essential medium (MEM; Earle's saits, supplied glutamine-free) supplemented with 10% heat-inactivated horse serum, 10% fetal bovine serum, glutamine (2 mM), and glucose (total 21 mM). Cultures were kept at 3]oC in a humidified CO2-containing atmo sphere. After 5-12 days in vitro, nonneuronal cell division was halted by 1-to 3-day exposure to 10-5 M cytosine arabinoside, and the cells were shifted into a maintenance medium identical to the plating medium but lacking fetal serum. Subsequent medium replacement was carried out twice per week. Cultures were studied between 15 and 20 days in vitro, by which time neurons develop an exten sive network of processes and distinctive phase-bright cell bodies while astrocytes form a confluent mat of phase-dark polygonal cells (Choi et aI., 1987) .
Glucose deprivation
Glucose deprivation was initiated by thoroughly ex changing the culture medium for a defined exposure so lution containing the following salts: NaCI 116 mM, KCl 5.4 mM, MgS04 0.8 mM, NaH2P04 1.0 mM, CaCl2 0.9 mM. This solution also contained added glutamine or other amino acids as appropriate to each experiment, but lacked glucose, serum, glutamate, or lactate dehydroge nase (LDH). Unless specified otherwise, amino acid con centrations were chosen to be the same as those present in Eagle's MEM. Cultures were then placed back in the 37°C incubator for 8-15 h. Monitoring of pH with phenol red indicator verified the absence of pH alteration during this glucose deprivation. Glucose deprivation was then terminated by the addition of a small amount of concen trated glucose to the exposure solution (final concentra tion 5.5 mM), and cultures were replaced in the incubator overnight (20-24 h) prior to assessing cell injury. In the presence of 2 mM glutamine, this protocol sufficed to produce substantial, but usually sub maximal , neuronal disintegration. Sham wash control cultures were treated in an identical fashion, except that the exposure solution used contained 5.5 mM glucose.
Assessment of neuronal cell injury
Neuronal cell injury was estimated in all experiments by examination of cultures with phase-contrast micros copy at 100-400 x. This examination was performed the day after initiation of glucose deprivation, at which point the process of cell death was largely complete. In most experiments, overall neuronal cell injury was also quan titatively assessed by the measurement of the cytosolic enzyme LDH in the extracellular fluid 1 day after glucose deprivation. This convenient index, corrected by sub tracting the small amount of LDH present in the medium of sister cultures subjected to sham wash, correlated well J Cereb Blood Flow Metab, Vol. 10, No.3, 1990 with the morphological estimate of neuronal damage. Pre vious experience has shown that medium LDH accu rately reflects the number of neurons damaged by brief exposure to either glutamate (Koh and Choi, 1987) or hypoxia (Goldberg et aI., 1987) , injury protocols that, like glucose deprivation, damage neurons but not glia.
Reagents
D-2-Amino-5-phosphonovalerate (D-APV) was ob tained from Tocris Neuramin. Dextrorphan was kindly supplied by Hoffmann-La Roche. L-Glutamine, L alanine, L-Ieucine, and L-glutamate were obtained from Sigma. Solutions of L-glutamine were stored at -70°C immediately after preparation (for <2 months) and thawed just before use.
RESULTS
As previously reported (Monyer et aI., 1989) , cor tical cultures deprived for 8-10 h of glucose in the presence of 2 mM glutamine and a standard set of other amino acids (as present in Eagle's MEM; see Materials and Methods) developed acute neuronal swelling and, by the next day, substantial neuronal degeneration associated with LDR efflux to the bathing medium (Fig. 1) . In contrast, the glial layer remained intact. This exposure duration was se lected to produce generally an intermediate (30-70% of the total neuronal population) level of neu ronal damage, a baseline appropriate for detecting either reduction or potentiation of injury. The exact extent of neuronal damage was quite reproducible among cultures derived from a single plating, but varied somewhat among cultures from different platings, presumably reflecting small variations in culture preparation. Both the morphological neuro nal disintegration and the efflux of LDH could be markedly reduced by the addition of 100 f.LM D-APV to the exposure solution (Fig. 1) . However, if the same glucose deprivation was carried out in an exposure solution lacking glu tamine, two alterations in resultant neuronal injury were consistently noted: (a) an increase in overall neuronal injury and (b) a marked decrease in the neuroprotective action of D-APV (Fig. O . The mag nitude of overall injury potentiation with glutamine withdrawal was dependent on the existing degree of neuronal loss; cultures already sustaining near max imal injury showed expectedly little further poten tiation of injury with glutamine removal. Further removal of all amino acids produced little additional change, except for a suggestion of slight reduction in overall injury (Fig. 1) .
We have previously demonstrated that the neu roprotective effect of D-APV against glucose depri vation is not absolute, but rather can be overcome by substantially increasing insult severity, accom plished by increasing the duration of glucose depri vation (Monyer et aI., 1989) . It seemed possible that the increase in glucose deprivation-induced neuro nal damage associated with glutamine withdrawal could itself account for the observed loss of D-APV protection, i.e., that the increase in injury was sufficient to simply override D-APV protection. However, this explanation was quantitatively inad equate. Increasing the duration of glucose depriva tion enough to more than mimic the injury potentiating effect of glutamine withdrawal did not lead to loss of D-APV protection (Fig. 2) . Thus, the observed loss of an NMDA receptor-mediated component of glucose deprivation-induced neuro nal injury likely reflected some specific effect of glutamine withdrawal.
Next, we considered the possibility that glu tamine was linked to NMDA receptor-mediated in jury because it directly activated NMDA receptors, because of either glutamate contamination or direct agonist properties. However, the measured amount of glutamate contamination was too low to produce neurotoxic activation of NMDA receptors. As as sayed by high performance liquid chromatography with o-phthaldialdehyde pre column derivatization and fluorescent detection, the glutamine lot used in these experiments was found to contain <0. 1 % glu tamate (Goldberg et aI., 1988) ; thus, 2 mM glu tamine contained <2 f.LM glutamate. Even addition of 20 f.LM glutamate to the exposure solution failed to induce a substantial NMDA receptor-mediated component to resultant injury (Fig. 3) . Further more, we have previously documented that 2 mM glutamine does not induce detectable neuronal in jury in the absence of oxygen or glucose deprivation (Goldberg et aI., 1988) .
Both potentiation of overall injury and loss of D APV protection associated with glutamine removal were glutamine concentration dependent (Fig. 4) . The EC50 for both effects was � 300 f.LM. At glu tamine concentrations below 300 f.LM, little of the observed injury was sensitive to D-APV.
The effects of glutamine removal could not be prevented by the substitution of 2 mM concentra tions of alanine or arginine (Fig. 5) . Similar lack of substitution was found with 2 mM leucine (not shown). Although a tendency toward overall irUury reduction was observed with the inclusion of these substitute amino acids in several experiments in volving shorter periods of glucose deprivation (6-8 h), with the standard 8-to lO-h glucose deprivation, neuronal damage was comparable with that seen after simple glutamine removal (Fig. 5) . In addition, little protective effect was produced by adding the NMDA antagonist 100 /J-M dextrorphan to the ex posure solution, in contrast to the near complete protection produced by dextrorphan in sister cul tures containing 2 mM glutamine (Fig. 5 ).
DISCUSSION
We have previously shown that cortical cultures deprived of glucose in the presence of 2 mM extra cellular glutamine developed widespread neuronal degeneration that could be attenuated by competi tive or noncompetitive NMDA antagonists (Monyer et aI., 1989) , suggesting that the neuronal degener ation was substantially mediated by the toxic ef fects of endogenously released glutamate or aspar tate. The central finding of the present study is that the nature of this glucose deprivation-induced neu ronal injury was modified by the removal of extra cellular glutamine. Two effects were observed: (a) potentiation of the overall amount of neuronal dam age and (b) marked reduction of the protective ef fect of NMDA antagonists, suggesting specific loss of the NMDA receptor-mediated component of in jury. Neither potentiation of neuronal injury nor glutamate contamination of the glutamine reagent was sufficient to account for the observed reduction in NMDA antagonist protection. Both effects of glutamine removal were glutamine concentration dependent and not reversed by substitution of equi molar concentrations of alanine, arginine, or leu cine.
These observations suggest that glucose depriva- . Control and -Gin conditions are as described in Fig. 1 ; in the -Gln/ + Ala condition, glutamine was omitted and 2 mM alanine was added. Error bars are SEM (n = 4). B: Same as A except that glutamine was re placed by 2 mM arginine. Error bars are SEM (n = 3 -4).
LOH, lactate dehydrogenase.
tion neuronal injury can be tonically regulated by the presence of extracellular glutamine. Of note, the observed EC50 for both amelioration of overall in jury and potentiation of NMDA receptor-mediated injury (300 /J-M) is near the glutamine concentra tions reported in cerebrospinal fluid (500 /J-M; Hagenfeldt et aI., 1984 ) and brain extracellular fluid in vivo (250 /J-M; Hagberg et aI., 1985) . It is thus conceivable that the availability of extracellular glu tamine may importantly influence the nature of hy poglycemic brain damage in vivo. Further study will be required to establish the exact mechanisms underlying the dependence of glucose deprivation neuronal injury on extracellular glutamine. Although withdrawal of medium glu tamine increased overall neuronal damage induced by glucose deprivation, it decreased the overall neuronal damage induced by hypoxia in the same system (Goldberg et aI. , 1988) . This difference un derscores the point that oxygen deprivation and glu cose deprivation are metabolically disparate condi tions. Despite appearing to substantially share an NMDA receptor-mediated component, hypoxia ischemia and hypoglycemia in vivo induced differ ent patterns of extracellular amino acid buildup and neuronal cell loss (Auer and Siesj6, 1988) . It is at tractive to speculate that the beneficial effect of glu tamine specific to glucose deprivation may reflect some ability of extracellular glutamine to maintain energy stores in the absence of glucose (Tildon, 1983) . There is substantial in vivo literature suggest ing that neurons can use a variety of alternative substrates, including amino acids, as fuel in hypo glycemia (Siesj6, 1988) .
In both glucose deprivation and hypoxia, with drawal of medium glutamine reduced the compo nent of neuronal damage mediated by NMDA re ceptors. Most likely, this effect reflects a critical role for glutamine in the synthesis of transmitter glutamate or aspartate. Removal of extracellular glutamine may limit the ability of excitatory nerve terminals to synthesize glutamate or aspartate, thereby reducing excitotoxicity when glucose is re moved. We cannot exclude the possibility that the effect of glutamine withdrawal on NMDA receptor mediated damage is a simple nonspecific concomi tant of further substrate depletion, but there are two arguments against this possibility: (a) Increasing the severity of the substrate depletion insult by extend ing exposure time did not mimic glutamine with drawal; and (b) the provision of alternative amino acid substrates did not prevent the effect of glu tamine withdrawal.
Present observations thus support the possibility that presynaptic strategies directed at reducing ex citatory transmitter synthesis or release may prove to be a useful adjunct, or even alternative, to antag onists of postsynaptic glutamate receptors in the therapy of clinical hypoglycemia or ischemia (Gold berg et aI. , 1989) . The first line of therapy for hy poglycemia is certainly administration of glucose, but it is conceivable that additional benefit could be gained by the pharmacological reduction of self propagating excitotoxic mechanisms triggered by the glucose deprivation.
However, it is clear that NMDA receptor mediated neurotoxicity accounts for only a portion of the neuronal injury associated with oxygen or glucose deprivation. Definition of other injury mechanisms may eventually allow the development of more powerful neuroprotective approaches than provided by NMDA antagonists alone. The model delineated here-glucose deprivation in the absence of extracellular glutamine-reproducibly produces neuronal injury that has little involvement of NMDA receptors and may prove helpful in the study of these other injury mechanisms.
